Tracleer and Gastrointestinal inflammation - a phase IV clinical study of FDA data

Summary:

Gastrointestinal inflammation is reported only by a few people who take Tracleer.

The phase IV clinical study analyzes which people take Tracleer and have Gastrointestinal inflammation. It is created by eHealthMe based on reports of 54,348 people who have side effects while taking Tracleer from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 16, 2022

54,348 people reported to have side effects when taking Tracleer.
Among them, 2 people (0.0%) have Gastrointestinal inflammation.


What is Tracleer?

Tracleer has active ingredients of bosentan. It is often used in primary pulmonary hypertension. eHealthMe is studying from 53,930 Tracleer users for its effectiveness, alternative drugs and more.

What is Gastrointestinal inflammation?

Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 772 drugs and 511 conditions by eHealthMe.

Number of Tracleer and Gastrointestinal inflammation reports submitted per year:

Could Tracleer cause Gastrointestinal inflammation?

Time on Tracleer when people have Gastrointestinal inflammation *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Gastrointestinal inflammation when taking Tracleer *:

  • female: 100 %
  • male: 0.0 %

Common drugs people take besides Tracleer *:

  1. Vitamin B12: 1 person, 50.00%
  2. Tylenol: 1 person, 50.00%
  3. Revatio: 1 person, 50.00%
  4. Rebif: 1 person, 50.00%
  5. Prograf: 1 person, 50.00%
  6. Prevacid: 1 person, 50.00%
  7. Oxybutynin: 1 person, 50.00%
  8. Omeprazole: 1 person, 50.00%
  9. Novalgin: 1 person, 50.00%
  10. Naproxen: 1 person, 50.00%

Common side effects people have besides Gastrointestinal inflammation *:

  1. Weight Increased: 1 person, 50.00%
  2. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 50.00%
  3. Alanine Aminotransferase Increased: 1 person, 50.00%
  4. Aspartate Aminotransferase Increased: 1 person, 50.00%
  5. Blood Disorder: 1 person, 50.00%
  6. Breathing Difficulty: 1 person, 50.00%
  7. Carcinoid Tumor Of The Duodenum: 1 person, 50.00%
  8. Dehydration (dryness resulting from the removal of water): 1 person, 50.00%
  9. Drug Ineffective: 1 person, 50.00%
  10. Eye Swelling: 1 person, 50.00%

Common conditions people have *:

  1. Weakness: 1 person, 50.00%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 50.00%
  3. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 1 person, 50.00%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 50.00%
  5. Fatigue (feeling of tiredness): 1 person, 50.00%
  6. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tracleer and have Gastrointestinal inflammation?

Check whether Gastrointestinal inflammation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Gastrointestinal inflammation and when was it recovered:

Expand to all the drugs that have ingredients of bosentan:

Alternative drugs to, pros and cons of Tracleer:

Common Tracleer side effects:

Browse all side effects of Tracleer:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gastrointestinal inflammation treatments and more:

COVID vaccines that are related to Gastrointestinal inflammation:

Common drugs associated with Gastrointestinal inflammation:

All the drugs that are associated with Gastrointestinal inflammation:

Common conditions associated with Gastrointestinal inflammation:

All the conditions that are associated with Gastrointestinal inflammation:

How the study uses the data?

The study uses data from the FDA. It is based on bosentan (the active ingredients of Tracleer) and Tracleer (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: